188 related articles for article (PubMed ID: 8927047)
1. Peroxovanadium compounds: biological actions and mechanism of insulin-mimesis.
Bevan AP; Drake PG; Yale JF; Shaver A; Posner BI
Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):49-58. PubMed ID: 8927047
[TBL] [Abstract][Full Text] [Related]
2. Early signaling events triggered by peroxovanadium [bpV(phen)] are insulin receptor kinase (IRK)-dependent: specificity of inhibition of IRK-associated protein tyrosine phosphatase(s) by bpV(phen).
Band CJ; Posner BI; Dumas V; Contreres JO
Mol Endocrinol; 1997 Dec; 11(13):1899-910. PubMed ID: 9415395
[TBL] [Abstract][Full Text] [Related]
3. Peroxovanadium compounds. A new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics.
Posner BI; Faure R; Burgess JW; Bevan AP; Lachance D; Zhang-Sun G; Fantus IG; Ng JB; Hall DA; Lum BS
J Biol Chem; 1994 Feb; 269(6):4596-604. PubMed ID: 8308031
[TBL] [Abstract][Full Text] [Related]
4. In vivo insulin mimetic effects of pV compounds: role for tissue targeting in determining potency.
Bevan AP; Burgess JW; Yale JF; Drake PG; Lachance D; Baquiran G; Shaver A; Posner BI
Am J Physiol; 1995 Jan; 268(1 Pt 1):E60-6. PubMed ID: 7840184
[TBL] [Abstract][Full Text] [Related]
5. Insulin receptor kinase-associated phosphotyrosine phosphatases in hepatic endosomes: assessing the role of phosphotyrosine phosphatase-1B.
Li C; Baquiran G; Gu F; Tremblay ML; Fazel A; Bergeron JJ; Posner BI
Endocrinology; 2006 Feb; 147(2):912-8. PubMed ID: 16269466
[TBL] [Abstract][Full Text] [Related]
6. A role for tyrosine phosphorylation in both activation and inhibition of the insulin receptor tyrosine kinase in vivo.
Drake PG; Bevan AP; Burgess JW; Bergeron JJ; Posner BI
Endocrinology; 1996 Nov; 137(11):4960-8. PubMed ID: 8895369
[TBL] [Abstract][Full Text] [Related]
7. Insulin receptor-associated protein tyrosine phosphatase(s): role in insulin action.
Drake PG; Posner BI
Mol Cell Biochem; 1998 May; 182(1-2):79-89. PubMed ID: 9609117
[TBL] [Abstract][Full Text] [Related]
8. A stable peroxovanadium compound with insulin-like action in human fat cells.
Eriksson JW; Lönnroth P; Posner BI; Shaver A; Wesslau C; Smith UP
Diabetologia; 1996 Feb; 39(2):235-42. PubMed ID: 8635677
[TBL] [Abstract][Full Text] [Related]
9. Insulin Signalling: The Inside Story.
Posner BI
Can J Diabetes; 2017 Feb; 41(1):108-113. PubMed ID: 27614806
[TBL] [Abstract][Full Text] [Related]
10. Hypoglycemic effects of peroxovanadium compounds in Sprague-Dawley and diabetic BB rats.
Yale JF; Lachance D; Bevan AP; Vigeant C; Shaver A; Posner BI
Diabetes; 1995 Nov; 44(11):1274-9. PubMed ID: 7589823
[TBL] [Abstract][Full Text] [Related]
11. Peroxovanadium-mediated protection against murine leishmaniasis: role of the modulation of nitric oxide.
Matte C; Marquis JF; Blanchette J; Gros P; Faure R; Posner BI; Olivier M
Eur J Immunol; 2000 Sep; 30(9):2555-64. PubMed ID: 11009089
[TBL] [Abstract][Full Text] [Related]
12. Selective activation of the rat hepatic endosomal insulin receptor kinase. Role for the endosome in insulin signaling.
Bevan AP; Burgess JW; Drake PG; Shaver A; Bergeron JJ; Posner BI
J Biol Chem; 1995 May; 270(18):10784-91. PubMed ID: 7537739
[TBL] [Abstract][Full Text] [Related]
13. Arrest at the G2/M transition of the cell cycle by protein-tyrosine phosphatase inhibition: studies on a neuronal and a glial cell line.
Faure R; Vincent M; Dufour M; Shaver A; Posner BI
J Cell Biochem; 1995 Nov; 59(3):389-401. PubMed ID: 8567756
[TBL] [Abstract][Full Text] [Related]
14. A peroxovanadium compound stimulates muscle glucose transport as powerfully as insulin and contractions combined.
Nolte LA; Han DH; Hansen PA; Hucker KA; Holloszy JO
Diabetes; 2003 Aug; 52(8):1918-25. PubMed ID: 12882906
[TBL] [Abstract][Full Text] [Related]
15. The chemistry of peroxovanadium compounds relevant to insulin mimesis.
Shaver A; Ng JB; Hall DA; Posner BI
Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):5-15. PubMed ID: 8927048
[TBL] [Abstract][Full Text] [Related]
16. Effects of bpV(pic) and bpV(phen) on H9c2 cardiomyoblasts during both hypoxia/reoxygenation and H2O2-induced injuries.
Tian Y; Daoud A; Shang J
Mol Med Rep; 2012 Mar; 5(3):852-8. PubMed ID: 22200881
[TBL] [Abstract][Full Text] [Related]
17. The insulinomimetic agents H2O2 and vanadate stimulate tyrosine phosphorylation of potential target proteins for the insulin receptor kinase in intact cells.
Heffetz D; Rutter WJ; Zick Y
Biochem J; 1992 Dec; 288 ( Pt 2)(Pt 2):631-5. PubMed ID: 1281409
[TBL] [Abstract][Full Text] [Related]
18. Multifunctional actions of vanadium compounds on insulin signaling pathways: evidence for preferential enhancement of metabolic versus mitogenic effects.
Fantus IG; Tsiani E
Mol Cell Biochem; 1998 May; 182(1-2):109-19. PubMed ID: 9609120
[TBL] [Abstract][Full Text] [Related]
19. Role of protein tyrosine phosphatases in the regulation of interferon-{gamma}-induced macrophage nitric oxide generation: implication of ERK pathway and AP-1 activation.
Blanchette J; Pouliot P; Olivier M
J Leukoc Biol; 2007 Mar; 81(3):835-44. PubMed ID: 17170076
[TBL] [Abstract][Full Text] [Related]
20. Hyperglycemia potentiates H(2)O(2) production in adipocytes and enhances insulin signal transduction: potential role for oxidative inhibition of thiol-sensitive protein-tyrosine phosphatases.
Wu X; Zhu L; Zilbering A; Mahadev K; Motoshima H; Yao J; Goldstein BJ
Antioxid Redox Signal; 2005; 7(5-6):526-37. PubMed ID: 15889998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
